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June Supplement 201158S AbstractsMethods: Peer-reviewed published studies on open
and endovascular treatment for AIOD since 1989 were
identified in PubMed, Medline, and EBSCOHost. Reports
were thoroughly analyzed, and those not meeting the
pre-defined inclusion criteria were excluded.
Results: Thirty-seven open studies with 6,618 patients
and 31 endovascular studies with 1,932 patients were in-
cluded in our analysis. Mean age was 60.7 years for open
and 60.5 years for endovascular patients. More patients
presented with critical limb ischemia in the open group
(35.5% vs. 23.6%, Odds Ratio [OR]: 1.8, p0.001) than
with claudication (65.6% vs. 76.2%, OR: 0.6, p0.001).
Mean overall follow-up time in months was greater in the
open than endovascular group (42.2 vs. 26.2, p0.001).
Poor preoperative runoff was greater in the open group
(47.1% vs. 25.0%, OR: 2.8, p0.001). No differences in
length of hospital stay (LOS) or increase in ankle-brachial
index were detected. The open group experienced more
systemic (9.5% vs. 3.5%, OR: 2.9, p0.001) than local
complications (4.6% vs. 13.3%, OR: 0.3, p0.001). Mor-
tality was greater in the open group (2.6% vs. 0.5%, OR:
5.3, p0.001), and secondary procedures were required
less frequently (4.1% vs. 8.5%, OR: 0.5, p0.001). Primary
patency rates at 1, 3, and 5 years were greater in the open
group (94.8% vs. 85.7%, OR: 3.0, p0.001; 87.7% vs.
78.9%, OR: 1.6, p0.001; 86.2% vs. 69.5%, OR: 2.4,
p0.001, respectively).
Conclusions: To our knowledge, this is the first sys-
tematic review comparing open and endovascular treat-
ment options for AIOD. These results demonstrate supe-
rior durability and equivalent LOS for open treatment with
an increased risk for systemic complications and mortality
when compared to the endovascular approach. Further
clinical studies are necessary to better characterize these
two treatment options.
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PS110.
Catheter-Directed Thrombolysis as First Line Treatment
of Acute Nontraumatic Upper Extremity Ischemia
A. M. Schrijver1, G. J. de Borst2, J. A. Vos1, J. A. van
Herwaarden2, D. A. Werson1, F. L. Moll2, J. P. de Vries1.
1St. Antonius Hospital, Nieuwegein, Netherlands; 2Uni-
versity Medical Center Utrecht, Utrecht, Netherlands
Objectives: Acute upper extremity ischemia is associ-
ated with substantial functional impairment. For many
years, surgical intervention has been the treatment of
choice, but perioperative mortality is up to 19%. Reports on
primary thrombolysis to treat acute upper extremity isch-
emia are scarce.
Methods: During a 4-year period all patients with
acute nontraumatic upper extremity ischemia (Rutherford
class 1 or 2a) undergoing catheter-directed thrombolysis as Crst line treatment were identified. One month follow-up
onsisted of duplex-scanning of the treated arm.
Results: From 2006 to 2010, 28 patients (22 women,
edian age 60 years, range 33-80) were treated with
hrombolysis for acute upper extremity ischemia. Occlu-
ions were localised as follows: subclavian artery (n8),
rachial artery (n6), radial and/or ulnar arteries (n11),
ypass graft (n3). Length of the occlusions was more
han 8 cm. Causes of occlusion were thromboembolic
n15), arterial thoracic outlet syndrome (n4), paraneo-
lastic (n1), and unknown (n8). Placement of a throm-
olysis catheter was unsuccessful in only 1 out of 28 pa-
ients. Median duration of thrombolysis was 24 hours
18-96). In 17 out of 28 patients complete lysis was
chieved, with complete resolution of symptoms. In 4
atients partial lysis was achieved; these patients were
symptomatic and therefore treated conservatively. In 7
atients no lysis was achieved; these were treated with
mbolectomy (n4), amputation (n2), and conserva-
ively (n1). During thrombolysis 1 patient had a throm-
oembolic complication of the lower limb, that was treated
uccessfully with thrombolysis and 1 had a transient isch-
mic attack.
At 1-month follow-up 2 reocclusions had occurred,
hat were treated successfully with percutaneous translumi-
al angioplasty (n1) and thrombolysis (n1).
Conclusions: Based on our results catheter-directed
hrombolysis is effective and safe as first line treatment of
cute nontraumatic upper extremity ischemia, in order to
revent or limit surgical intervention.
uthor Disclosures: G. J. de Borst: Nothing to disclose;
. P. de Vries: Nothing to disclose; F. L. Moll: Nothing to
isclose; A. M. Schrijver: Nothing to disclose; J. A. van
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ects of ESRD on Diabetic Patients
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tantinos T. Spyris, Sung yup Kim, Victoria J. Teodorescu,
indsor Ting, Sharif H. Ellozy, Michael L. Marin, Peter
aries. Vascular Surgery, The Mount Sinai Medical Center,
ew York, NY
Objectives: This study assesses the effects of end
tage renal disease (ESRD) on diabetic patients under-
oing percutaneous interventions for critical limb isch-
mia (CLI).
Methods: Eighty-three diabetic patients (15 with
SRD) requiring infrainguinal interventions were studied.
iabetics with and without ESRD were compared over 24
onths. Statistical analysis was conducted with SPSS soft-
are (SPSS Inc. Chicago, IL).
Results: Diabetic patients with ESRD presented with
LI at an earlier age (64.5 vs. 71.8 years, p0.012) and
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Volume 53, Number 17S Abstracts 59Swere more likely to be hypertensive (p0.002), present
with tissue loss (94.7% vs. 47.6%, p0.000), and have tibial
vessel disease (51.2% vs. 25.5%, p0.005). There were no
differences in primary procedures or peri-procedural
complications; however, diabetics with ESRD had antlmost 4-fold increase in length of stay (19.3 vs. 5.02
ays, p0.001; Fig 1). The groups had no differences in
atency rates, but diabetics with ESRD exhibited inferior
imb salvage (p0.006; Fig 2) and decreased overall
urvival (p0.022; Fig 3).
Conclusions:ESRD is associated withmore challenges
n diabetic patients treated for CLI. In our cohort, ESRD
id not affect long term patency rates after endovascular
rocedures, but substantially increased length of stay and
as associated with worse limb salvage and poorer long
erm survival.
uthor Disclosures: S. H. Ellozy: Nothing to disclose; P.
aries: Nothing to disclose; S. Kim: Nothing to disclose;
. L. Marin: Nothing to disclose; C. T. Spyris: Nothing
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herif Sultan2, Wael Tawfick1. 1Vascular & Endovascular
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ay Clinic, Galway, Ireland
Objectives: Endovascular revascularization (EvR) for
ritical lower ischemia (CLI) should be complemented
y non-invasive imaging for arterial mapping. Duplex
ltrasound arterial mapping (DUAM) can precisely dis-
riminate between echolucency due to thrombus vs ath-
rosclerotic occlusion. Our endeavour is to appraise
UAM as the exclusive imaging modality when planning
or CLI EvR.
Methods: Primary endpoint is sensitivity and specificity
f DUAM, compared to magnetic resonance angiogram
MRA) or DSA. Secondary endpoints were procedural,
emodynamic, clinical outcomes, cost-effectiveness, and
mputation-free survival.
DUAM was the sole pre-operative mapping modality.
RA was only used where DUAMwas inconclusive due to
eavy calcification.
From 2002 to 2009, 3490patients were referred with
eripheral vascular disease. 483patients underwent revascu-
arisation for TASC C/D lesions (EvR:n310; bypass
urgery[BS]:n173).
Results: DUAM displayed 97% sensitivity and 98%
pecificity in identifying lesions requiring intervention.
RA was utilized in 62 patients (12.8%) with 82% speci-
city. DUAM accurately identified the total number of
arget lesions for revascularisation (TLR) however MRA
